Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 1526 - 1550 of 2342 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG02
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261677 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI04
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260551 1456.901753 C72H132N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC04
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Lewis a(d18:1/22:0)
44260631 1456.901753 C72H132N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD04
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type I H antigen(d18:1/22:0)
44260639 1456.901753 C72H132N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB04
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Lex-5(d18:1/22:0)
44260983 1456.901753 C72H132N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD04
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type II antigen(d18:1/22:0)
44260999 1456.901753 C72H132N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV04
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261607 1456.901753 C72H132N2O27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE03
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • SSEA-3 antigen(d18:1/20:0)
44260198 1444.865368 C70H128N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP03
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260286 1444.865368 C70H128N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA03
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260374 1444.865368 C70H128N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK03
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260454 1444.865368 C70H128N2O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ03
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260558 1444.865368 C70H128N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AQ03
  • Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260742 1444.865368 C70H128N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU03
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260966 1444.865368 C70H128N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC03
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260990 1444.865368 C70H128N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ03
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • galgactosyl-paraglobside(d18:1/20:0)
44261254 1444.865368 C70H128N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BK03
  • Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261262 1444.865368 C70H128N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AN03
  • Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261918 1444.865368 C70H128N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AS03
  • Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • iGb5(d18:1/20:0)
44261582 1444.865368 C70H128N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AU03
  • Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261598 1444.865368 C70H128N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BE03
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261662 1444.865368 C70H128N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AU05
  • Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260328 1443.906504 C72H133NO27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AU07
  • Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260330 1441.890854 C72H131NO27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM04
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260263 1431.870119 C70H129NO28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC01
  • Forssman antigen(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260180 1429.829317 C68H123N3O28

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024